Donanemab trials for Alzheimer Disease

All Donanemab trials · All Alzheimer Disease trials

Phase breakdown

Recruiting trials studying Donanemab for Alzheimer Disease

• A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
  NCT06566170 · Phase: Not specified · Ages: 60 Years and older · Sex: All (male and female) · 1 location
• A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
  NCT07602582 · Phase: Phase 3 · Ages: 55 Years and older · Sex: All (male and female) · 59 locations
• Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
  NCT07571161 · Phase: Phase 3 · Ages: 55 Years to 80 Years · Sex: All (male and female) · 30 locations

Common questions

How many trials study Donanemab for Alzheimer Disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.